# Stefano Taddei

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/stefano-taddei/

## Facts

| Field | Value |
| --- | --- |
| Citations | 43,059 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 88 |
| i10-index | 318 |
| Last Known Institution | University of Pisa |
| OpenAlex ID | https://openalex.org/A5027821454 |
| ORCID iD | 0000-0002-5002-3070 |
| Works | 925 |

## Researcher papers

Showing 12 of 13.

- [Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure](https://scholariq.org/papers/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/)
- [Empagliflozin in Heart Failure with a Preserved Ejection Fraction](https://scholariq.org/papers/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/)
- [2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension](https://scholariq.org/papers/2023-esh-guidelines-for-the-management-of-arterial-hypertension-the-task-force/)
- [The Assessment of Endothelial Function](https://scholariq.org/papers/the-assessment-of-endothelial-function/)
- [Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans](https://scholariq.org/papers/expert-consensus-and-evidence-based-recommendations-for-the-assessment-of-flow/)
- [Vitamin C Improves Endothelium-Dependent Vasodilation by Restoring Nitric Oxide Activity in Essential Hypertension](https://scholariq.org/papers/vitamin-c-improves-endothelium-dependent-vasodilation-by-restoring-nitric-oxide/)
- [Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*](https://scholariq.org/papers/endothelial-function-and-dysfunction-part-ii-association-with-cardiovascular/)
- [Aging and Endothelial Function in Normotensive Subjects and Patients With Essential Hypertension](https://scholariq.org/papers/aging-and-endothelial-function-in-normotensive-subjects-and-patients-with/)
- [Age-Related Reduction of NO Availability and Oxidative Stress in Humans](https://scholariq.org/papers/age-related-reduction-of-no-availability-and-oxidative-stress-in-humans/)
- [Endothelial function and dysfunction. Part I](https://scholariq.org/papers/endothelial-function-and-dysfunction-part-i/)
- [Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial](https://scholariq.org/papers/dual-endothelin-antagonist-aprocitentan-for-resistant-hypertension-precision-a/)
- [Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study](https://scholariq.org/papers/randomized-trial-on-the-effects-of-a-combined-physical-cognitive-training-in/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiovascular Health and Disease Prevention](https://scholariq.org/topics/cardiovascular-health-and-disease-prevention/)
- [Nitric Oxide and Endothelin Effects](https://scholariq.org/topics/nitric-oxide-and-endothelin-effects/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Cardiovascular Disease and Adiposity](https://scholariq.org/topics/cardiovascular-disease-and-adiposity/)

## Researcher university

- [University of Pisa](https://scholariq.org/institutions/university-of-pisa/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.